HCM NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

HUTCHMED DRC · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 12.51 USD
12.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -4.9% below the Trend Line and sits at 32.1% of its 52-week range. The latest completed week returned 12.4%, after a 13.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 27/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: volume confirmation is below normal.

Setup score 31 out of 100
Latest Close 12.51 USD 7 Aug 2026
1W Return 12.4% latest completed week
4W Return 13.0% short-term follow-through
12W Return 0.0% quarterly tape
Trend Breadth 19.2% 10 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 12.4% Latest completed week; four-week move 13.0%. Indicator stack 11/45 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 27/100 conviction; expected move 20.4%. News sentiment 61/100 46 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -4.9% below the Trend Line and sits at 32.1% of its 52-week range. The latest completed week returned 12.4%, after a 13.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0412-week average 0.12

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 13.0% over four weeks, 0.0% over 12 weeks, and -16.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W12.4%
4W13.0%
12W0.0%
26W-17.6%
52W-16.6%
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.51Latest activity-pressure read.
Pressure change52.4%Four-week change in activity pressure.
Leadership-22.51Latest relative-leadership reading.
RS change35.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value37/100Relative valuation strength. Underlying universe rank 64; rank 1 is best.
Quality6/100Profitability and accounting quality. Underlying universe rank 95; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth7/100Revenue and earnings growth. Underlying universe rank 94; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
9.2x
Price divided by trailing earnings.
Price / sales
4.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
5.9%
Gross profit retained from each unit of revenue.
Operating margin
-6.7%
Operating profit retained from revenue.
Free-cash-flow margin
-1.8%
Free cash flow generated from revenue.
Return on invested capital
-2.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-10.9%
Latest one-year revenue growth.
EPS growth
-5.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-760.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
-0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

HCM shows mixed options pressure with a 27/100 conviction score, put-call volume ratio of n/a, expected move of 20.4%, and Sharemaestro trend signal inactive.

Conviction27/100
Expected move20.4%
Put/call volume
Pressure-1
Speculation0
Volatility92
Trend agreement68
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment61/100

Weighted news tone is neutral across 46 relevant articles.

21 positive · 23 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move20.4%Nearest-chain priced movement where available.
52-week drawdown-31.6%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+12.5%Week of 3 Jul.
Worst week-11.1%Week of 24 Apr.
Latest week+12.4%Week of 7 Aug.

Shape of recent returns

Strong gains3
Modest gains6
Flat weeks0
Modest losses9
Sharp losses8
Recent vol5.9%13-week weekly-return volatility.
Base vol5.5%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.04; No reversal markers Factors13/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 71; Small Cap Core rank 67 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options49/100

HCM shows mixed options pressure with a 27/100 conviction score, put-call volume ratio of n/a, expected move of 20.4%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 20.4% Sentiment61/100

Weighted news tone is neutral across 46 relevant articles.

HUTCHMED (NASDAQ:HCM) Announces Earnings Results Insiders50/100

No recent insider transaction evidence is stored.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202612.51 USD12.4%13.15 USD15.74 USD-0.51-22.51190.8KOff
31 Jul 202611.13 USD1.1%13.23 USD15.75 USD-0.91-28.10209.5KOff
24 Jul 202611.01 USD1.6%13.31 USD15.79 USD-0.88-29.39283.5KOff
17 Jul 202610.84 USD-2.1%13.40 USD15.81 USD-0.99-32.45210.7KOff
10 Jul 202611.07 USD-3.2%13.49 USD15.82 USD-1.06-34.75234.8KOff
3 Jul 202611.44 USD12.5%13.57 USD15.83 USD-1.12-32.12345.6KOff
26 Jun 202610.17 USD-1.1%13.66 USD15.84 USD-1.25-39.75202.3KOff
19 Jun 202610.28 USD-6.2%13.80 USD15.85 USD-1.22-42.45163.4KOff
12 Jun 202610.96 USD0.8%13.93 USD15.85 USD-1.12-37.72209.3KOff
5 Jun 202610.87 USD-5.1%14.07 USD15.87 USD-1.11-37.64599.7KOff
29 May 202611.45 USD-4.5%14.20 USD15.88 USD-1.14-37.93216.2KOff
22 May 202611.99 USD-4.2%14.31 USD15.89 USD-1.04-33.70225.1KOff
15 May 202612.51 USD-4.7%14.40 USD15.89 USD-0.87-30.50148.2KOff
8 May 202613.13 USD-1.3%14.49 USD15.90 USD-0.32-27.73123.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context